Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Specifications: Odor and taste: Almost odorless, sour taste Arsenic (As): 2 ppm Heavy Metals : 10 ppm Identification (IR): Corresponds Identification (Lead Acetate): Positive Identification (Ninhydrin): Positive Iron (Fe): 10 ppm Loss on Drying: 0.5 % Optical Rotation: - 21 - -11 Residue on Ignition: 0.1 % Research or further manufacturing use only, not for food or drug use.
NAD+ IV Therapy: NAD+ is a coenzyme that is involved in many important cellular processes
[PubMed] [Springer] ASHP, Acetylcysteine (Monograph)
[7] The protein encoded by this gene protects from CD95-induced apoptosis in cultured breast cancer cells and inhibits 5-lipoxygenase in blood cells, and its overexpression delays endothelial cell death and increases resistance to toxic challenges, especially oxidative stress
Additional information Peer review information Nature Communications thanks Neil McDonald, Felix Weis, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Operational Dosing and Label Literacy Research dose context: GHRP-2 has been administered in human pharmacodynamic studies most commonly at 1 microgram per kilogram intravenously or subcutaneously
